Cole, Patrick <br/><br/>
The soluble tumor necrosis factor receptor etanercept: a new strategy for the treatment of autoimmune rheumatic disease.  [electronic resource] 

 -  Drugs of today (Barcelona, Spain : 1998)  Apr 2004 
 - 281-324 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1699-3993 
<br/><br/><label>Standard No.: </label>10.1358/dot.2004.40.4.820078  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antirheumatic Agents--administration & dosage<br/>Arthritis, Rheumatoid--drug therapy<br/>Clinical Trials as Topic<br/>Cost-Benefit Analysis<br/>Dose-Response Relationship, Drug<br/>Drug Therapy, Combination<br/>Etanercept<br/>Humans<br/>Immunoglobulin G--administration & dosage<br/>Methotrexate--administration & dosage<br/>Quality of Life<br/>Receptors, Tumor Necrosis Factor--administration & dosage<br/>Recombinant Fusion Proteins--therapeutic use<br/>Severity of Illness Index<br/>Treatment Outcome<br/>Tumor Necrosis Factor-alpha--antagonists & inhibitors